RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 48 filers reported holding RECRO PHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $370,683 | -55.6% | 790,167 | +4.0% | 0.00% | – |
| Q2 2023 | $835,607 | +11.9% | 759,643 | +21.1% | 0.00% | – |
| Q1 2023 | $746,423 | +131081.5% | 627,247 | +64.1% | 0.00% | – |
| Q4 2022 | $569 | -99.9% | 382,339 | +2.4% | 0.00% | – |
| Q3 2022 | $608,000 | +106.8% | 373,304 | +0.7% | 0.00% | – |
| Q2 2022 | $294,000 | -56.1% | 370,529 | -0.4% | 0.00% | – |
| Q1 2022 | $669,000 | +11.3% | 372,005 | +5.7% | 0.00% | – |
| Q4 2021 | $601,000 | -15.7% | 351,786 | +1.6% | 0.00% | – |
| Q3 2021 | $713,000 | +0.8% | 346,208 | +13.0% | 0.00% | – |
| Q2 2021 | $707,000 | -28.1% | 306,269 | -13.1% | 0.00% | – |
| Q1 2021 | $983,000 | +32.1% | 352,367 | +34.9% | 0.00% | – |
| Q4 2020 | $744,000 | +31.7% | 261,292 | -2.9% | 0.00% | – |
| Q3 2020 | $565,000 | -54.1% | 269,157 | -0.6% | 0.00% | – |
| Q2 2020 | $1,232,000 | -48.4% | 270,820 | -7.3% | 0.00% | -100.0% |
| Q1 2020 | $2,387,000 | -77.3% | 292,187 | -49.0% | 0.00% | 0.0% |
| Q4 2019 | $10,502,000 | +212.7% | 572,988 | +89.0% | 0.00% | 0.0% |
| Q3 2019 | $3,358,000 | +3.1% | 303,155 | -5.4% | 0.00% | 0.0% |
| Q2 2019 | $3,258,000 | +179.2% | 320,425 | +60.9% | 0.00% | – |
| Q1 2019 | $1,167,000 | -47.9% | 199,155 | -37.0% | 0.00% | – |
| Q4 2018 | $2,242,000 | +124.2% | 315,906 | +124.6% | 0.00% | – |
| Q3 2018 | $1,000,000 | +49.5% | 140,654 | +5.4% | 0.00% | – |
| Q2 2018 | $669,000 | -49.0% | 133,416 | +11.9% | 0.00% | – |
| Q1 2018 | $1,312,000 | +23.8% | 119,233 | +4.0% | 0.00% | – |
| Q4 2017 | $1,060,000 | +2.4% | 114,667 | -0.6% | 0.00% | – |
| Q3 2017 | $1,035,000 | +29.4% | 115,358 | +1.3% | 0.00% | – |
| Q2 2017 | $800,000 | +3.1% | 113,859 | +28.1% | 0.00% | – |
| Q1 2017 | $776,000 | +44.8% | 88,853 | +33.5% | 0.00% | – |
| Q4 2016 | $536,000 | +135.1% | 66,565 | +158.0% | 0.00% | – |
| Q3 2016 | $228,000 | +11.8% | 25,801 | +0.1% | 0.00% | – |
| Q2 2016 | $204,000 | +33.3% | 25,775 | 0.0% | 0.00% | – |
| Q1 2016 | $153,000 | -34.1% | 25,775 | -0.1% | 0.00% | – |
| Q4 2015 | $232,000 | -24.9% | 25,801 | +0.2% | 0.00% | – |
| Q3 2015 | $309,000 | +19.8% | 25,749 | +28.8% | 0.00% | – |
| Q2 2015 | $258,000 | +94.0% | 19,984 | +36.1% | 0.00% | – |
| Q1 2015 | $133,000 | +224.4% | 14,684 | 0.0% | 0.00% | – |
| Q4 2014 | $41,000 | -4.7% | 14,684 | 0.0% | 0.00% | – |
| Q3 2014 | $43,000 | -63.2% | 14,684 | 0.0% | 0.00% | – |
| Q2 2014 | $117,000 | – | 14,684 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MAK CAPITAL ONE LLC | 850,129 | $2,423,000 | 0.65% |
| Newtyn Management, LLC | 700,000 | $1,995,000 | 0.46% |
| Portolan Capital Management | 1,293,376 | $3,686,000 | 0.34% |
| Rubric Capital Management LP | 1,076,587 | $3,068,000 | 0.22% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 99,046 | $282,000 | 0.04% |
| Alyeska Investment Group, L.P. | 736,821 | $2,100,000 | 0.03% |
| STEPHENS INC /AR/ | 510,569 | $1,455,000 | 0.03% |
| Clear Harbor Asset Management, LLC | 46,682 | $133,000 | 0.02% |
| WYNNEFIELD CAPITAL INC | 13,000 | $37,000 | 0.02% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 451,301 | $1,286,000 | 0.01% |